Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis

Peng Chen, Qibiao Wu, Jiao Feng, Lili Yan, Yitian Sun, Shuiping Liu, Xiang Yu, Mingming Zhang, Ting Pan, Xiaying Chen, Ting Duan, Lijuan Zhai, Bingtao Zhai, Wengang Wang, Ruonan Zhang, Bi Chen, Xuemeng Han, Yicong Li, Liuxi Chen, Ying Liu, Xingxing Huang, Ting Jin, Wenzheng Zhang, Hong Luo, Xiaohong Chen, Yongqiang Li, Qiujie Li, Guohua Li, Qin Zhang, Lvjia Zhuo, Zuyi Yang, Huifen Tang, Tian Xie, Xiaoping Ouyang, Xinbing SuiSignal 2020 · DOI

Abstract

Ferroptosis, a novel form of programmed cell death, is characterized by iron-dependent lipid peroxidation and has been shown to be involved in multiple diseases, including cancer. Stimulating ferroptosis in cancer cells may be a potential strategy for cancer therapy. Therefore, ferroptosis-inducing drugs are attracting more attention for cancer treatment. Here, we showed that erianin, a natural product isolated from Dendrobium chrysotoxum Lindl, exerted its anticancer activity by inducing cell death and inhibiting cell migration in lung cancer cells. Subsequently, we demonstrated for the first time that erianin induced ferroptotic cell death in lung cancer cells, which was accompanied by ROS accumulation, lipid peroxidation, and GSH depletion. The ferroptosis inhibitors Fer-1 and Lip-1 but not Z-VAD-FMK, CQ, or necrostatin-1 rescued erianin-induced cell death, indicating that ferroptosis contributed to erianin-induced cell death. Furthermore, we demonstrated that $\text{Ca}^{2+}$/CaM signaling was a critical mediator of erianin-induced ferroptosis and that blockade of this signaling significantly rescued cell death induced by erianin treatment by suppressing ferroptosis. Taken together, our data suggest that the natural product erianin exerts its anticancer effects by inducing $\text{Ca}^{2+}$/CaM-dependent ferroptosis and inhibiting cell migration, and erianin will hopefully serve as a prospective compound for lung cancer treatment.

Introduction

Lung cancer remains the leading cause of cancer-related mortality worldwide. Despite advancements in surgery, chemotherapy, and immunotherapy, many patients experience recurrence or treatment failure due to the development of drug resistance. Most conventional therapies aim to trigger apoptosis, but cancer cells frequently evolve mechanisms to evade this pathway. Consequently, identifying alternative cell death pathways is crucial for improving patient outcomes.

Ferroptosis is a recently identified form of regulated cell death driven by iron-dependent lipid peroxidation. Unlike apoptosis, ferroptosis is characterized by the accumulation of reactive oxygen species (ROS) and the depletion of glutathione (GSH), leading to lethal membrane damage. This study investigates erianin, a natural dibenzyl compound derived from the Dendrobium orchid, and its potential to induce ferroptosis in lung cancer cells.

Methods

The researchers utilized H460 and H1299 human lung cancer cell lines. Cell viability and proliferation were assessed using CCK-8 and colony formation assays. Cell migration was evaluated via wound-healing and Transwell assays. To identify the mode of cell death, specific inhibitors were used: Fer-1 and Lip-1 for ferroptosis, Z-VAD-FMK for apoptosis, CQ for autophagy, and necrostatin-1 for necroptosis.

Biochemical markers of ferroptosis, including ROS levels, GSH depletion, and malondialdehyde (MDA) levels (a marker of lipid peroxidation), were measured. Mitochondrial morphology was observed using Transmission Electron Microscopy (TEM). Intracellular calcium and iron levels were tracked via flow cytometry. Finally, RNA sequencing and KEGG pathway analysis were performed to elucidate the molecular mechanisms, and the anti-tumor efficacy of erianin was validated in vivo using mouse xenograft models.

Results and Discussion

Erianin Potently Inhibits Lung Cancer Cell Proliferation

Erianin exhibited significant anti-proliferative effects on lung cancer cells in a dose- and time-dependent manner. As shown in Figure 4, treatment with erianin led to a marked increase in the percentage of cell death and a substantial reduction in colony formation for both H460 and H1299 cells.

Erianin induces cell death and inhibits colony formation in H460 and H1299 lung cancer cells.

The inhibitory effect was also time-dependent, as demonstrated in H1299 cells where growth was progressively suppressed over 72 hours of treatment (Figure 1).

Time- and dose-dependent growth inhibition of H1299 cells by erianin treatment.

Induction of Ferroptosis via Calcium/Calmodulin Signaling

A key finding of this study is that erianin-induced cell death is primarily driven by ferroptosis. This was confirmed by the fact that only ferroptosis inhibitors (Fer-1 and Lip-1) could rescue the cells from erianin-induced death. Biochemical analysis revealed the classic hallmarks of ferroptosis: increased ROS and lipid peroxidation, GSH depletion, and downregulation of GPX4, the cell's primary defense against ferroptosis.

Mechanistically, erianin treatment triggered a surge in intracellular $\text{Ca}^{2+}$, which activated Calmodulin (CaM). This $\text{Ca}^{2+}$/CaM signaling was found to be a critical mediator; blocking this pathway prevented erianin-induced ferroptosis. Furthermore, erianin inhibited cell migration by reversing the Epithelial-Mesenchymal Transition (EMT), downregulating markers like vimentin and N-cadherin.

In Vivo Efficacy and Safety

In mouse xenograft models, erianin (100 mg/kg) significantly suppressed tumor volume and bioluminescence without causing detectable toxicity to major organs. This suggests that erianin is not only effective but also has a favorable safety profile for potential clinical application.

Conclusion

Erianin represents a promising novel therapeutic agent for lung cancer. By inducing $\text{Ca}^{2+}$/CaM-dependent ferroptosis and inhibiting cell migration, it offers a strategy to bypass apoptosis resistance. Future research should focus on mapping the precise downstream targets of the CaM-iron axis and optimizing the pharmacokinetics of erianin for human use.

Summary updated

Abstract

Ferroptosis, a novel form of programmed cell death, is characterized by iron-dependent lipid peroxidation and has been shown to be involved in multiple diseases, including cancer. Stimulating ferroptosis in cancer cells may be a potential strategy for cancer therapy. Therefore, ferroptosis-inducing drugs are attracting more attention for cancer treatment. Here, we showed that erianin, a natural product isolated from Dendrobium chrysotoxum Lindl, exerted its anticancer activity by inducing cell death and inhibiting cell migration in lung cancer cells. Subsequently, we demonstrated for the first time that erianin induced ferroptotic cell death in lung cancer cells, which was accompanied by ROS accumulation, lipid peroxidation, and GSH depletion. The ferroptosis inhibitors Fer-1 and Lip-1 but not Z-VAD-FMK, CQ, or necrostatin-1 rescued erianin-induced cell death, indicating that ferroptosis contributed to erianin-induced cell death. Furthermore, we demonstrated that Ca<sup>2+</sup>/CaM signaling was a critical mediator of erianin-induced ferroptosis and that blockade of this signaling significantly rescued cell death induced by erianin treatment by suppressing ferroptosis. Taken together, our data suggest that the natural product erianin exerts its anticancer effects by inducing Ca<sup>2+</sup>/CaM-dependent ferroptosis and inhibiting cell migration, and erianin will hopefully serve as a prospective compound for lung cancer treatment.
BibTeX
@inproceedings{chen2020erianin,
  author = {Peng Chen and Qibiao Wu and Jiao Feng and Lili Yan and Yitian Sun and Shuiping Liu and Xiang Yu and Mingming Zhang and Ting Pan and Xiaying Chen and Ting Duan and Lijuan Zhai and Bingtao Zhai and Wengang Wang and Ruonan Zhang and Bi Chen and Xuemeng Han and Yicong Li and Liuxi Chen and Ying Liu and Xingxing Huang and Ting Jin and Wenzheng Zhang and Hong Luo and Xiaohong Chen and Yongqiang Li and Qiujie Li and Guohua Li and Qin Zhang and Lvjia Zhuo and Zuyi Yang and Huifen Tang and Tian Xie and Xiaoping Ouyang and Xinbing Sui},
  title = {{Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis}},
  booktitle = {Signal},
  year = {2020},
  doi = {10.1038/s41392-020-0149-3},
}
Figure